We are live on
!
Find out more
AC
Amia Capital Portfolio holdings
AUM
$32.1M
1-Year Est. Return
0.56%
This Fund
S&P 500
This Quarter
Est. Return
-4.57%
1 Year Est. Return
+0.56%
3 Year Est. Return
+30.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$86.1M
AUM Growth
-$35.6M
(-29%)
Cap. Flow
-$31.4M
Cap. Flow
% of AUM
-36.45%
Top 10 Holdings %
Top 10 Hldgs %
85.07%
Holding
39
New
1
Increased
10
Reduced
24
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vale
VALE
|
+$6.18M |
| 2 |
Petrobras
PBR
|
+$2.12M |
| 3 |
MTEM
Molecular Templates, Inc.
MTEM
|
+$223K |
| 4 |
Fate Therapeutics
FATE
|
+$118K |
| 5 |
Black Diamond Therapeutics
BDTX
|
+$82.3K |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 47.91% |
| 2 | Materials | 11.06% |
| 3 | Energy | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MYOV
26
DELISTED
Myovant Sciences Ltd.
MYOV
| $353K | 0.41% |
25,111
-1,959
| -7% | -$36.4K |
|
27
Scholar Rock
SRRK
$5.71B
| $262K | 0.3% |
14,821
+13
| +0.1% | +$193 |
|
28
Nektar Therapeutics
NKTR
$2.39B
| $237K | 0.28% |
953
-29
| -3% | -$9.12K |
|
|
29
Black Diamond Therapeutics
BDTX
$101M
| $229K | 0.27% |
7,589
+2,703
| +55% | +$82.3K |
|
|
MTEM
30
DELISTED
Molecular Templates, Inc.
MTEM
| $205K | 0.24% |
+1,254
| New | +$223K |
|
|
SGMO
31
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $199K | 0.23% |
21,018
-626
| -3% | -$6.77K |
|
32
Voyager Therapeutics
VYGR
$187M
| $156K | 0.18% |
14,632
-438
| -3% | -$5.14K |
|
33
Wave Life Sciences
WVE
$1.12B
| $121K | 0.14% |
14,211
+705
| +5% | +$7.73K |
|
|
KZR
34
DELISTED
Kezar Life Sciences
KZR
| $112K | 0.13% |
2,315
+1,004
| +77% | +$48K |
|
|
CDTX
35
DELISTED
Cidara Therapeutics
CDTX
| $44K | 0.05% |
770
-33
| -4% | -$2.33K |
|
36
Arvinas
ARVN
$518M
| – | – |
-6,974
| Closed | -$234K |
|
37
iShares Biotechnology ETF
IBB
$9.31B
| – | – |
-5,015
| Closed | -$686K |
|
38
CALL
Invesco QQQ Trust
QQQ
$455B
| – | – |
-46,800
| Closed | -$468K |
|
|
AKCA
39
DELISTED
Akcea Therapeutics Inc
AKCA
| – | – |
-13,761
| Closed | -$189K |
|
Similar funds
QI
SAM
FCMI
AG
NLG
BEVI
BGDR
TAAM
Amia Capital's Q3 2020 Portfolio in Review
As of Q3 2020, Amia Capital held 39 positions worth $86.1M, down 29% from $122M the previous quarter. Its ten largest holdings account for 85% of the portfolio.
Amia Capital withdrew a net $31.4M in Q3 2020, closing 4 positions and reducing 24 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $686K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 43% a quarter earlier, followed by Materials and Energy.
Against the trend, Amia Capital opened a new position in Molecular Templates, Inc. worth $205K.
- Amia Capital's largest Q3 2020 buy was Molecular Templates, Inc.: 1,254 shares worth $205K.
- Amia Capital added most to Vale in Q3 2020, an estimated $6.18M increase.
- Amia Capital's biggest Q3 2020 reduction was BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares), cutting an estimated $17.3M.
- Amia Capital fully exited iShares Biotechnology ETF in Q3 2020, selling an estimated $686K.
- Amia Capital's ten largest holdings make up 85% of its $86.1M portfolio in Q3 2020.
- Amia Capital opened 1 new position and closed 4 in Q3 2020.
- Amia Capital's portfolio value fell 29% quarter-over-quarter to $86.1M.
Based on Amia Capital's 13F filing for Q3 2020, filed 16 Nov 2020.